Literature DB >> 26300019

IL-17 polymorphisms and asthma risk: a meta-analysis of 11 single nucleotide polymorphisms.

Yan Jin1, Zaichun Deng2, Chao Cao2, Longxiang Li1.   

Abstract

OBJECTIVE: There has been significant interest in the association between asthma and the polymorphisms of IL-17A and IL-17F for a period of time. This work aims to present a clearer relationship between asthma and the polymorphisms of IL-17A and IL-17F.
METHOD: Searches were performed in Medline, EMBASE, and the Chinese National Knowledge Infrastructure (CNKI) databases. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the relationship between polymorphisms of IL-17A and IL-17F and asthma.
RESULTS: Nine studies comprising 3650 asthmatics and 3370 controls were included in this meta-analysis for all single nucleotide polymorphisms (SNPs) (2-6 per SNP). Our study examined the polymorphisms of IL-17F rs1889570 (C/T) (CC versus TT: OR = 0.55, 95%CI = 0.41-0.75; CT versus TT: OR = 0.54, 95%CI = 0.40-0.72; CC/CT versus TT: OR = 0.55, 95%CI = 0.42-0.72; CC versus CT/TT, OR = 1.83, 95%CI = 1.39-2.41), IL-17A rs4711998(A/G) (AA/AG versus GG: OR = 0.67, 95%CI = 0.46-0.98), and IL-17A rs3819024(A/G) (AA versus GG: OR = 1.77, 95%CI = 1.39-2.25) and found they were significantly related to the risk of asthma.
CONCLUSION: Our systematic review showed that IL-17F rs1889570(C/T), IL-17A rs4711998(A/G) and IL-17A rs3819024(A/G) may be potential risk factors for asthma susceptibility.

Entities:  

Keywords:  Asthma; IL-17A; IL-17F; meta-analysis; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26300019     DOI: 10.3109/02770903.2015.1044251

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  7 in total

1.  Association of rs4711998 of IL-17A, rs2275913 of IL-17A and rs763780 IL-17F gene polymorphisms with non-segmental vitiligo in a Mexican population.

Authors:  Natalia Aranza Zapata-Salazar; David Emmanuel Kubelis-Lopez; Mauricio Andres Salinas-Santander; Celia Nohemi Sanchez-Dominguez; Ana Cecilia Xolalpa-Rosales; Marely Eugenia Gomez-Galindo; Jorge Ocampo-Candiani
Journal:  Arch Dermatol Res       Date:  2022-08-12       Impact factor: 3.033

Review 2.  Gene polymorphisms in asthma: a narrative review.

Authors:  Fei Shi; Yu Zhang; Chen Qiu
Journal:  Ann Transl Med       Date:  2022-06

3.  A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

Authors:  Carolina Martínez-Laperche; Elena Buces; M Carmen Aguilera-Morillo; Antoni Picornell; Milagros González-Rivera; Rosa Lillo; Nazly Santos; Beatriz Martín-Antonio; Vicent Guillem; José B Nieto; Marcos González; Rafael de la Cámara; Salut Brunet; Antonio Jiménez-Velasco; Ildefonso Espigado; Carlos Vallejo; Antonia Sampol; José María Bellón; David Serrano; Mi Kwon; Jorge Gayoso; Pascual Balsalobre; Álvaro Urbano-Izpizua; Carlos Solano; David Gallardo; José Luis Díez-Martín; Juan Romo; Ismael Buño
Journal:  Blood Adv       Date:  2018-07-24

4.  Haplotype of the Interleukin 17A gene is associated with osteitis after Bacillus Calmette-Guerin vaccination.

Authors:  Matti Korppi; Johanna Teräsjärvi; Milla Liehu-Martiskainen; Eero Lauhkonen; Juho Vuononvirta; Kirsi Nuolivirta; Liisa Kröger; Laura Pöyhönen; Minna K Karjalainen; Qiushui He
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

5.  G Protein-Coupled Receptor Kinase 2 (GRK2) Regulates T Cell Response in a Murine Model of House Dust Mite-Induced Asthma.

Authors:  Ananth K Kammala; Canchai Yang; Reynold A Panettieri; Rupali Das; Hariharan Subramanian
Journal:  Front Allergy       Date:  2021-05-17

6.  Bcl11b Regulates IL-17 Through the TGF-β/Smad Pathway in HDM-Induced Asthma.

Authors:  Si Chen; Yuting Han; Hao Chen; Jing Wu; Min Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2018-09       Impact factor: 5.764

7.  Relationship between asthma and IL-17 gene polymorphism in a Turkish population.

Authors:  Gülbahar Darılmaz Yüce; Tuba Erdoğan; Bülent Bozkurt; Uğur Toprak; Gülay Güleç Ceylan
Journal:  Ir J Med Sci       Date:  2022-03-24       Impact factor: 1.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.